Benzonatate and Silvadene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Silvadene (silver sulfadiazine). Common drug interactions include irritable bowel syndrome among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Silvadene. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Silvadene?

Silvadene has active ingredients of silver sulfadiazine. eHealthMe is studying from 1,161 Silvadene users. Check the latest studies of Silvadene.



On Jul, 12, 2026

21 people who take Benzonatate and Silvadene together, and have interactions are studied.

Benzonatate and Silvadene drug interactions.

What are the common drug interactions of Benzonatate and Silvadene, by gender? *:

female:

  1. Irritable bowel syndrome
  2. Joint crepitation
  3. Klebsiella infection
  4. Klebsiella test positive
  5. Lethargy (tiredness)
  6. Liver disorder (liver diseases)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Memory impairment
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Pain

male:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Pain
  4. Pertussis (whooping cough: a disease of the respiratory mucous membrane)
  5. Renal injury (kidney injury)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Stress
  8. Tooth loss
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  10. Anxiety

What are the common drug interactions of Benzonatate and Silvadene, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hallucination, auditory (perceiving sounds without auditory stimulus)
  2. Pertussis (whooping cough: a disease of the respiratory mucous membrane)

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Pain
  6. Blood hiv rna increased
  7. Chronic kidney disease
  8. Osteoporosis (bones weak and more likely to break)
  9. Osteoporotic fracture (fracture due to weak bone)
  10. Synovial cyst (cyst of joint filled with synovial fluid)

50-59:

  1. Abdominal hernia
  2. Abdominal pain lower
  3. Arthralgia (joint pain)
  4. Back pain
  5. Body temperature increased
  6. Bone pain
  7. Breast cellulitis (spreading, acute inflammation of beast skin)
  8. Breast pain
  9. Chest discomfort
  10. Chest pain

60+:

  1. Breast cancer
  2. Hypertension (high blood pressure)
  3. Disease progression
  4. Drug hypersensitivity
  5. Fatigue (feeling of tiredness)
  6. Fibromyalgia (a long-term condition which causes pain all over the body)
  7. Hepatic enzyme increased
  8. Nausea (feeling of having an urge to vomit)
  9. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  10. Renal injury (kidney injury)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 33.33%
  2. Osteoporosis (bones weak and more likely to break): 4 people, 19.05%
  3. Vitamin B12 Deficiency: 3 people, 14.29%
  4. Urinary Tract Infection: 3 people, 14.29%
  5. Upper Respiratory Tract Infection: 3 people, 14.29%
  6. Sinusitis (inflammation of sinus): 3 people, 14.29%
  7. Rickets (softening of bones): 3 people, 14.29%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 14.29%
  10. Hiv Infection: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Silvadene?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benzonatate and Silvadene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Silvadene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benzonatate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Silvadene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate and silver sulfadiazine (the active ingredients of Benzonatate and Silvadene, respectively), and Benzonatate and Silvadene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: